The PTPN22 C1858T variant as a risk factor for rheumatoid arthritis and systemic lupus erythematosus but not for systemic sclerosis in the Colombian population

CER4424
2012 Vol.30, N°4
PI 0520, PF 0524
Full Papers

Free to view
(click on article PDF icon to read the article)

PMID: 22704547 [PubMed]

Received: 29/12/2010
Accepted : 29/11/2011
In Press: 29/08/2012
Published: 29/08/2012

Abstract

OBJECTIVES:
C1858T single nucleotide polymorphism in PTPN22 encoding the R620W allele variant of Lyp-PTPN22 (a protein phosphatase negatively regulating T-cell activation) has been associated with autoimmunity. This work has investigated the possible association between PTPN22 C1858T (rs2476601) polymorphism and rheumatoid arthritis (RA), systemic lupus erythematosus (SLE) and systemic sclerosis (SSc) in a Colombian population.
METHODS:
A case-control study included 1,042 samples from 413 RA, 94 SLE and 101 SSc patients and 434 healthy controls. The TaqMan allele discrimination assay was used for genotyping.
RESULTS:
The case-control study provided robust evidence of association between allele 1858T and RA (p=5E–05), as well as between 1858T and SLE (p=0.004). These observations were confirmed for both diseases by meta-analysis (p=2E–04, pooled OR 1.9; 1.3–2.7 95% CI for RA; p<0.0001, pooled OR 2.8, 1.8–4.5 95% CI for SLE). No significant association was observed between 1858T and SSc (p=0.98, OR 1.11, 0.46–2.65 95% CI).
CONCLUSIONS:
The study suggested that the PTPN22 1858T variant influences RA and SLE genetic background but not that of SSc in the Colombian population.